|
Market Closed -
Sao Paulo
12:59:53 30/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 85.86 BRL | -0.42% |
|
+3.50% | +9.74% |
| 28/09 | UBS Raises Vertex Pharmaceuticals Price Target to $615 From $585, Maintains Buy Rating | MT |
| 23/09 | TD Cowen Adjusts PT on Vertex Pharmaceuticals to $550 From $525, Maintains Buy Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.33% | +0.53% | +0.03% | -3.53% | +7.67% | +51.65% | +115.42% | +400.79% | +1,341.66% | 1,05600Cr | |
| -1.06% | -1.65% | -0.42% | +4.24% | +27.92% | +42.78% | +69.98% | +63.93% | +124.11% | 64TCr | |
| -0.65% | -1.32% | +2.02% | +3.95% | +14.49% | +12.98% | +75.49% | +142.50% | +314.76% | 47TCr | |
| -2.66% | -1.87% | -1.66% | +13.08% | +38.05% | +73.13% | +41.15% | +93.46% | +132.83% | 37TCr | |
| -0.06% | -4.12% | -2.68% | +3.04% | +6.37% | +36.31% | +39.39% | +3.27% | +44.38% | 34TCr | |
| -0.79% | +3.01% | -3.05% | -4.94% | +9.45% | +21.11% | +27.79% | +55.33% | +55.29% | 28TCr | |
| -1.19% | -1.21% | +2.59% | -12.91% | -10.95% | +9.82% | +10.61% | +37.08% | +145.40% | 25TCr | |
| -0.50% | +3.80% | -1.95% | +16.40% | +28.78% | +49.37% | +56.84% | +98.22% | +152.69% | 23TCr | |
| -1.47% | -1.53% | +1.85% | +17.98% | +21.44% | +34.28% | +98.89% | +113.39% | +88.38% | 19TCr | |
| +0.62% | -2.16% | -14.31% | -19.59% | -22.15% | -27.97% | -60.68% | -17.42% | +80.86% | 17TCr | |
| -0.70% | +1.21% | +0.21% | +18.44% | +14.54% | +11.93% | -14.02% | -33.69% | -15.80% | 16TCr | |
| -0.74% | +1.25% | -3.99% | +5.25% | +15.32% | +33.49% | +50.35% | +188.22% | +499.48% | 13TCr | |
| -0.73% | +2.04% | -6.60% | +8.30% | +15.68% | +38.36% | +7.51% | +5.46% | +15.73% | 13TCr | |
| -1.27% | -3.03% | -3.56% | +13.00% | +4.09% | +10.52% | +96.35% | +328.23% | +412.03% | 10TCr | |
| -1.29% | -2.86% | -1.16% | -7.52% | +0.41% | +16.35% | +22.79% | +4.42% | -10.80% | 9.82TCr | |
| +1.64% | -2.35% | -5.97% | -3.79% | -12.19% | -7.20% | -28.42% | -13.22% | +6.78% | 9.7TCr | |
| -5.35% | +5.74% | +37.22% | +174.98% | +553.00% | +645.53% | +86.44% | -49.96% | - | 8.12TCr | |
| +1.03% | -5.43% | -5.11% | +21.61% | -1.76% | +34.86% | -7.86% | +25.30% | +88.61% | 7.49TCr | |
| +0.51% | +3.72% | -1.53% | -5.67% | +12.64% | +28.70% | -12.68% | -25.45% | +44.03% | 6.77TCr | |
| Average | -0.34% | -0.03% | -0.42% | +12.75% | +38.04% | +58.74% | +35.54% | +74.73% | +195.58% | 25.95TCr | |
| Weighted average by Cap. | -0.77% | -0.16% | -0.68% | +5.33% | +21.71% | +44.40% | +57.26% | +138.02% | +400.36% |
- Stock Market
- Stocks
- VRTX Stock
- VRTX34 Stock
- Sector Vertex Pharmaceuticals Incorporated
Select your edition
All financial news and data tailored to specific country editions
